Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Remdesivir and tocilizumab: Mix or match.
Akinosoglou K, Velissaris D, Ziazias D, Davoulos C, Tousis A, Tsiotsios K, Kalogeropoulou C, Spyridonidis A, Marangos M, Fligkou F, Gogos C. Akinosoglou K, et al. Among authors: spyridonidis a. J Med Virol. 2021 Jan;93(1):56-58. doi: 10.1002/jmv.26117. Epub 2020 Jun 19. J Med Virol. 2021. PMID: 32492200 Free PMC article. No abstract available.
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3.
Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB; BMT-CTN 1506/MORPHO Study Investigators. Levis MJ, et al. J Clin Oncol. 2024 May 20;42(15):1766-1775. doi: 10.1200/JCO.23.02474. Epub 2024 Mar 12. J Clin Oncol. 2024. PMID: 38471061 Free PMC article. Clinical Trial.
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S, Labopin M, Salmenniemi U, Socié G, Bondarenko S, Blaise D, Kröger N, Vydra J, Grassi A, Bonifazi F, Czerw T, Anagnostopoulos A, Lioure B, Ruggeri A, Savani B, Spyridonidis A, Sanz J, Peric Z, Nagler A, Ciceri F, Mohty M. Giebel S, et al. Among authors: spyridonidis a. Cancer. 2023 Dec 1;129(23):3735-3745. doi: 10.1002/cncr.35004. Epub 2023 Sep 1. Cancer. 2023. PMID: 37658621 Free article.
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT.
Sanz J, Labopin M, Versluis J, Blaise D, Lazzari L, Montoro J, Van Gorkom G, von dem Borne P, Sandrine L, Rovira M, Reményi P, Chevallier P, Kwon M, Eder M, Vydra J, Brissot E, Spyridonidis A, Piemontese S, Mohty M, Ciceri F. Sanz J, et al. Among authors: spyridonidis a. Bone Marrow Transplant. 2025 Apr;60(4):529-534. doi: 10.1038/s41409-025-02527-z. Epub 2025 Feb 12. Bone Marrow Transplant. 2025. PMID: 39939431
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Maffini E, Ngoya M, Galimard JE, Harbi S, Kröger N, Platzbecker U, Sengeloev H, Craddock C, Potter V, Choi G, Chevallier P, Stölzel F, Tholouli E, Maertens J, Ciceri F, Cornelissen J, Sanz J, Spyridonidis A, Lanza F, Nagler A, Mohty M. Maffini E, et al. Among authors: spyridonidis a. Bone Marrow Transplant. 2023 Sep;58(9):1033-1041. doi: 10.1038/s41409-023-02027-y. Epub 2023 Jun 29. Bone Marrow Transplant. 2023. PMID: 37386253
The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide.
Spyridonidis A, Labopin M, Savani BP, Kulagin A, Blaise D, Broers AEC, Sica S, Raiola AM, Vydra J, Choi G, Rovira M, Kwon M, Sanz J, Itäla-Remes M, von dem Borne P, Esquirol A, Koc Y, Brissot E, Nagler A, Mohty M, Ciceri F. Spyridonidis A, et al. Bone Marrow Transplant. 2025 Apr;60(4):499-506. doi: 10.1038/s41409-025-02514-4. Epub 2025 Feb 5. Bone Marrow Transplant. 2025. PMID: 39910175
Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
Lagadinou ED, Marangos M, Liga M, Panos G, Tzouvara E, Dimitroulia E, Tiniakou M, Tsakris A, Zoumbos N, Spyridonidis A. Lagadinou ED, et al. Among authors: spyridonidis a. Transpl Infect Dis. 2010 Oct;12(5):437-40. doi: 10.1111/j.1399-3062.2010.00515.x. Transpl Infect Dis. 2010. PMID: 20561301
SARS-CoV-2 persistence and non-protective immunity in infected haematological patients.
Akinosoglou K, Paliogianni F, Spyridonidis A, Symeonidis A, Alexopoulos LG, Ziazias D, Kouraklis-Symeonidis A, Marangos M, Gogos C. Akinosoglou K, et al. Among authors: spyridonidis a. Br J Haematol. 2021 Jan;192(2):e51-e54. doi: 10.1111/bjh.17212. Epub 2020 Nov 20. Br J Haematol. 2021. PMID: 33216364 Free PMC article. No abstract available.
154 results